Tilman Sauerbruch chercheur
Sauerbruch, Tilman 1946-
Sauerbruch, Tilman
VIAF ID: 5462148037711888350007 (Personal)
Permalink: http://viaf.org/viaf/5462148037711888350007
Preferred Forms
-
100 1 _
‡a
Sauerbruch, Tilman
-
100 1 _ ‡a Sauerbruch, Tilman
-
100 1 _
‡a
Sauerbruch, Tilman
‡d
1946-
-
100 0 _
‡a
Tilman Sauerbruch
‡c
chercheur
4xx's: Alternate Name Forms (4)
5xx's: Related Names (3)
- 551 _ _
‡a
Lauingen (Donau)
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _
‡a
Medizinische Klinik und Poliklinik I - Allgemeine Innere Medizin
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
Rheinische Friedrich-Wilhelms-Universität Bonn
‡b
Medizinische Fakultät
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
| Title | Sources |
|---|---|
| Bile acids, liver cirrhosis, and extrahepatic vascular dysfunction |
|
| Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction |
|
| Hepatitis C, the silent epidemic |
|
| Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study |
|
| Is detection of bacterial DNA in ascitic fluid of clinical relevance? |
|
| Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis. |
|
| Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase? |
|
| Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Durchführung endoskopischer Untersuchungen |
|
| Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis |
|
| Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation |
|
| Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C |
|
| Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients |
|
| Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. |
|
| Neutropenic enterocolitis in adults: systematic analysis of evidence quality |
|
| Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma |
|
| p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ |
|
| Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells |
|
| Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis |
|
| Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma |
|
| Phospholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestations |
|
| Pitfalls in the diagnosis of intestinal tuberculosis: a case report |
|
| Plasminogen fragment K1-3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver |
|
| The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis |
|
| Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse drug reaction |
|
| Prediction of glomerular filtration rate in renal transplant recipients: cystatin C or modification of diet in renal disease equation? |
|
| The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation |
|
| Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2. |
|
| Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study |
|
| Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy |
|
| Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides |
|
| Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study |
|
| Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding |
|
| Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis |
|
| Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis |
|
| PS-023-Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS |
|
| Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome |
|
| Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction |
|
| Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model |
|
| Regulation of CC chemokine receptor 5 in hepatitis G virus infection |
|
| Regulation of NK cell trafficking by CD81. |
|
| Regulatory mechanisms underlying agmatine homeostasis in humans |
|
| Reply to the comment on "atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?" by Matsushita et al. |
|
| Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice |
|
| Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C. |
|
| Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis |
|
| Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts |
|
| The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS. |
|
| Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level |
|
| Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C |
|
| Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). |
|
| Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients |
|
| Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. |
|
| Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care |
|
| siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo |
|
| Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival |
|
| Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension. |
|
| Statins as a Therapy of Chronic Liver Disease? |
|
| Statins improve NASH via inhibition of RhoA and Ras. |
|
| Susceptibility to spontaneous bacterial peritonitis--are genetics the future? |
|
| The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS |
|
| TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor |
|
| Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial |
|
| Therapie-Handbuch - Gastroenterologie und Hepatologie |
|
| Time course of low molecular weight proteins in the early kidney transplantation period--influence of corticosteroids |
|
| The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. |
|
| Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites |
|
| Toxic damage increases angiogenesis and metastasis in fibrotic livers via PECAM-1. |
|
| TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. |
|
| The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C. |
|
| Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis |
|
| Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension |
|
| The treatment of patients with HIV |
|
| Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) |
|
| Udenafil – A New Phosphodiesterase-5 (PDE-5) Inhibitor – in Portal Hypertension: An Open-Label Dose-Finding Trial |
|
| Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study |
|
| Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test. |
|
| Validation of the CKD-EPI formula in patients after renal transplantation. |
|
| Vanishing bile duct syndrome associated with elevated pancreatic enzymes after short-term administration of amoxicillin |
|
| Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins |
|
| Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis |
|
| β-Arrestin2 is increased in liver fibrosis in humans and rodents |
|
